The average one-year price target for Tonix Pharmaceuticals Holding Corp. is $ The forecasts range from a low of $ to a high of $ A stock's. Valuation: Tonix Pharmaceuticals ; P/E ratio * · EV / Sales * · Yield *. Over the last year, Tonix Pharmaceuticals shares have traded in a share price range of $ to $ Tonix Pharmaceuticals currently has 22,, shares. The current price of TNXP is USD — it has decreased by −% in the past 24 hours. Watch Tonix Pharmaceuticals Holding Corp. stock price performance. News & Events · Sep 4, am EDT. As Research Into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets It With FDA-.
TNXP Stock Overview · Revenue is forecast to grow % per year · Trading at good value compared to peers and industry · Highly volatile share price over the. On Wednesday morning 09/04/ the Tonix Pharmaceuticals Holding Corp Registered Shs share started trading at the price of $ Compared to the closing price. Get Tonix Pharmaceuticals Holding Corp (TNXP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Tonix Pharmaceuticals Holding Corp. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. m ; Total Shares. m. Monday, July 01, · Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract. Vandana Singh - Jul 1, , AM · Tonix. Latest News ; Tonix Collaborates With Bilthoven Biologicals To Advance Mpox Vaccine Candidate 'TNX'; Stock Up. Aug 26, · RTTNews ; WHO Declares Monkeypox. Get the latest Tonix Pharmaceuticals Holding Corp. (TNXP) stock news and headlines to help you in your trading and investing decisions. Today, $TNXP announced a collaboration with Bilthoven Biologics (BBIO), a global vaccine company, to advance development of Tonix's mpox vaccine, TNX According to 2 analysts, the average rating for TNXP stock is "Strong Buy." The month stock price forecast is $, which is an increase of 32,% from. Forte Biosciences Inc. $ FBRX % ; Applied DNA Sciences Inc. $ APDN % ; Vaxart Inc. $ VXRT % ; Sangamo Therapeutics Inc. $ SGMO. Based on 1 Wall Street analysts offering 12 month price targets for Tonix Pharma in the last 3 months. The average price target is $ with a high forecast of.
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small. As Research Into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront – Tonix Targets It With FDA-Fast Track-Designated TNX SL. Track Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Tonix Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple. Tonix Pharma stock news, updates & related news. Find out why Tonix Pharma's (TNXP) news sentiment is % more negative in relation to stocks in the. Based on short-term price targets offered by three analysts, the average price target for Tonix Pharmaceuticals Holding Corp. comes to $ The forecasts. Tonix Pharma to offer and sell shares of common stock. Jul 8, • RTTNews Markets Tonix Pharma granted up to $34 mln 5-year DoD contract for antiviral. Latest News ; Tonix Collaborates With Bilthoven Biologicals To Advance Mpox Vaccine Candidate 'TNX'; Stock Up. Aug 26, · RTTNews ; WHO Declares Monkeypox. About Tonix Pharmaceuticals Hld (TNXP) ; Avg. daily volume. M ; EBITDA (TTM). -$M ; Open. $ ; Price / earnings ratio. x ; Yesterday's range. $
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of Recent News Shares of Tonix Pharmaceuticals Holding Corp. gained % in premarket trading on Wednesday after the company said the U.S. Patent and Trademark. View today's Tonix Pharmaceuticals Holding Corp stock price and latest TNXP news and analysis. Create real-time notifications to follow any changes in the. View Tonix Pharmaceuticals (TNXP) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Tonix Pharmaceuticals Holding Corp. ; FY Estimate Trends · -$ · -$ ; FY Estimate Trends · -$ · -$ ; Q3 Estimate Trends · -$ · -$.
THE MINISTRY OF HEALTH ADDRESS THE PUBLIC ON MPOX VIRUS
Tonix Pharmaceuticals Holding Corp NASDAQ: TNXP is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small. Ratings · Tonix Pharmaceuticals Secures $34M DoD Contract for Antiviral Program · Express News | Tonix Pharmaceuticals Holding Corp - Program to Develop Orally.